---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/250092732.md"
description: "China Science Sun Pharm is in talks to authorize weight loss drugs in the United States. (Reuters)"
datetime: "2025-07-25T07:54:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250092732.md)
  - [en](https://longbridge.com/en/news/250092732.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250092732.md)
generator: "portal-rs"
---

# 

China Science Sun Pharm is in talks to authorize weight loss drugs in the United States. (Reuters)

### Related Stocks

- [300485.CN](https://longbridge.com/en/quote/300485.CN.md)

## Related News & Research

- [Roularta Media Group posts H1 2026 results press release](https://longbridge.com/en/news/296573558.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [California helicopter maker wins major role in US Army pilot training](https://longbridge.com/en/news/296642218.md)
- [Globo deploys Enensys DTV+ headend to broadcast FIFA World Cup 2026 matches in 4K](https://longbridge.com/en/news/296495715.md)
- [Max Power to present Lawson natural hydrogen discovery at IMAGE ’26 in Houston](https://longbridge.com/en/news/296226273.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**